#Vienna #Austria #RNA Sequencing #Lexogen #Austrian Innovation

Lexogen's Recognition in Austria

Lexogen has recently been honored as one of the top innovative companies in Austria for 2026, according to Statista and trend. magazine. This accolade reflects Lexogen's steadfast commitment to innovation in the fields of RNA sequencing and transcriptome analysis, marking it as a leader in the biotechnology sector.

The Significance of the Award

The annual ranking emphasizes companies that exemplify creativity, embrace technological advancements, and cultivate a progressive corporate culture. Lexogen's inclusion in this prestigious list stems from a meticulous evaluation process by experts in the field, who recognize the significant contributions the company makes to science and technology.

Lexogen's Mission

Established nearly two decades ago in Vienna, Lexogen has consistently aimed to empower scientists in their exploration of gene functionality. By developing sophisticated technologies for RNA analysis, Lexogen provides critical insights into gene expression, which has become essential for various research applications. Their technologies play a vital role not only in basic research but also in practical applications, such as healthcare, drug discovery, and personalized medicine. For instance, by identifying the origins of cancer, their tools facilitate tailored treatment plans for patients, significantly impacting healthcare outcomes.

Commitment to Quality

Lexogen is committed to maintaining high standards in its product development and manufacturing processes. All of its products are developed and produced in-house at its headquarters in Vienna, adhering to the ISO 9001:2015 and ISO 13485:2016 standards. This rigorous quality assurance guarantees that Lexogen's products meet the strict requirements necessary for diagnostic applications. Currently, the company has 17 patent families protecting its groundbreaking innovations, which have significantly advanced the landscape of RNA research.

Global Operations

Operating on an international scale, Lexogen has established a subsidiary in the United States and collaborates with over 30 distributors globally, making its innovative solutions accessible to scientists in more than 60 countries. This widespread availability is a testament to Lexogen's dedication to fostering scientific research worldwide.

The Culture of Innovation

At the core of Lexogen's success is a culture that values innovation, collaboration, and continuous improvement. Stéphane Barges, CEO of Lexogen, articulates that innovation is not solely about technology; it embodies the company's ethos and influences everyday interactions. Lexogen promotes a workplace where employees are encouraged to share ideas, take initiatives, and learn from failures, fostering an environment that thrives on creativity and cooperation. The company's core values drive its operations, ensuring that the focus remains on building trust and empowering team members.

Conclusion

The recognition from Statista and trend. magazine underscores Lexogen's ongoing commitment to cultivating a culture that values scientific curiosity and honest collaboration. By consistently prioritizing innovation and quality, Lexogen has not only established itself as a trusted leader in RNA sequencing but also as a vital contributor to the advancement of life science research on a global scale. This honor serves as a reminder of Lexogen's influence in the biotechnology landscape and its potential to shape the future of scientific discovery. For additional details about Lexogen and its offerings, visit their website at www.lexogen.com or follow them on social media @lexogen.